世界の神経科学抗体＆アッセイ市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Neuroscience Antibodies and Assays Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z4101 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、95ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥565,500 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥848,250 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,131,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、神経科学抗体＆アッセイのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（消耗品、器具）、用途別市場規模（製薬＆バイオテクノロジー企業、学術＆研究所、病院＆診断センター）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・神経科学抗体＆アッセイの市場動向 ・企業の競争状況、市場シェア ・神経科学抗体＆アッセイの種類別市場規模（消耗品、器具） ・神経科学抗体＆アッセイの用途別市場規模（製薬＆バイオテクノロジー企業、学術＆研究所、病院＆診断センター） ・神経科学抗体＆アッセイの北米市場規模2016-2027（アメリカ、カナダ） ・神経科学抗体＆アッセイのヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・神経科学抗体＆アッセイのアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・神経科学抗体＆アッセイの中南米市場規模2016-2027（メキシコ、ブラジル） ・神経科学抗体＆アッセイの中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Thermo Fisher、Abcam、Bio-Rad、Merck、Cell Signaling Technology、Genscript、Rockland Immunochemicals、BioLegend、Santa Cruz Biotechnology、Roche、Siemens） ・結論

The demand for Neuroscience Antibodies and Assays is increasing, due to the rising incidence of neurological diseases, increasing investments in neuroscience research, and growth in the pharmaceutical and biotechnology industries.

Market Analysis and Insights: Global Neuroscience Antibodies and Assays Market
The global Neuroscience Antibodies and Assays market size is projected to reach US$ 3489.1 million by 2026, from US$ 2343.5 million in 2019, at a CAGR of 5.8% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Neuroscience Antibodies and Assays market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Neuroscience Antibodies and Assays market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Neuroscience Antibodies and Assays market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Neuroscience Antibodies and Assays market.

Global Neuroscience Antibodies and Assays Scope and Market Size
Neuroscience Antibodies and Assays market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Neuroscience Antibodies and Assays market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Consumables
Instruments

Segment by Application
Pharmaceutical & Biotechnology Companies
Academic & Research Institutes
Hospitals & Diagnostic Centers

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Thermo Fisher
Abcam
Bio-Rad
Merck
Cell Signaling Technology
Genscript
Rockland Immunochemicals
BioLegend
Santa Cruz Biotechnology

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Neuroscience Antibodies and Assays Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Consumables
1.2.3 Instruments
1.3 Market by Application
1.3.1 Global Neuroscience Antibodies and Assays Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Pharmaceutical & Biotechnology Companies
1.3.3 Academic & Research Institutes
1.3.4 Hospitals & Diagnostic Centers
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Neuroscience Antibodies and Assays Market Perspective (2016-2027)
2.2 Neuroscience Antibodies and Assays Growth Trends by Regions
2.2.1 Neuroscience Antibodies and Assays Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Neuroscience Antibodies and Assays Historic Market Share by Regions (2016-2021)
2.2.3 Neuroscience Antibodies and Assays Forecasted Market Size by Regions (2022-2027)
2.3 Neuroscience Antibodies and Assays Industry Dynamic
2.3.1 Neuroscience Antibodies and Assays Market Trends
2.3.2 Neuroscience Antibodies and Assays Market Drivers
2.3.3 Neuroscience Antibodies and Assays Market Challenges
2.3.4 Neuroscience Antibodies and Assays Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Neuroscience Antibodies and Assays Players by Revenue
3.1.1 Global Top Neuroscience Antibodies and Assays Players by Revenue (2016-2021)
3.1.2 Global Neuroscience Antibodies and Assays Revenue Market Share by Players (2016-2021)
3.2 Global Neuroscience Antibodies and Assays Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Neuroscience Antibodies and Assays Revenue
3.4 Global Neuroscience Antibodies and Assays Market Concentration Ratio
3.4.1 Global Neuroscience Antibodies and Assays Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Neuroscience Antibodies and Assays Revenue in 2020
3.5 Neuroscience Antibodies and Assays Key Players Head office and Area Served
3.6 Key Players Neuroscience Antibodies and Assays Product Solution and Service
3.7 Date of Enter into Neuroscience Antibodies and Assays Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Neuroscience Antibodies and Assays Breakdown Data by Type
4.1 Global Neuroscience Antibodies and Assays Historic Market Size by Type (2016-2021)
4.2 Global Neuroscience Antibodies and Assays Forecasted Market Size by Type (2022-2027)

5 Neuroscience Antibodies and Assays Breakdown Data by Application
5.1 Global Neuroscience Antibodies and Assays Historic Market Size by Application (2016-2021)
5.2 Global Neuroscience Antibodies and Assays Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Neuroscience Antibodies and Assays Market Size (2016-2027)
6.2 North America Neuroscience Antibodies and Assays Market Size by Type
6.2.1 North America Neuroscience Antibodies and Assays Market Size by Type (2016-2021)
6.2.2 North America Neuroscience Antibodies and Assays Market Size by Type (2022-2027)
6.2.3 North America Neuroscience Antibodies and Assays Market Size by Type (2016-2027)
6.3 North America Neuroscience Antibodies and Assays Market Size by Application
6.3.1 North America Neuroscience Antibodies and Assays Market Size by Application (2016-2021)
6.3.2 North America Neuroscience Antibodies and Assays Market Size by Application (2022-2027)
6.3.3 North America Neuroscience Antibodies and Assays Market Size by Application (2016-2027)
6.4 North America Neuroscience Antibodies and Assays Market Size by Country
6.4.1 North America Neuroscience Antibodies and Assays Market Size by Country (2016-2021)
6.4.2 North America Neuroscience Antibodies and Assays Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Neuroscience Antibodies and Assays Market Size (2016-2027)
7.2 Europe Neuroscience Antibodies and Assays Market Size by Type
7.2.1 Europe Neuroscience Antibodies and Assays Market Size by Type (2016-2021)
7.2.2 Europe Neuroscience Antibodies and Assays Market Size by Type (2022-2027)
7.2.3 Europe Neuroscience Antibodies and Assays Market Size by Type (2016-2027)
7.3 Europe Neuroscience Antibodies and Assays Market Size by Application
7.3.1 Europe Neuroscience Antibodies and Assays Market Size by Application (2016-2021)
7.3.2 Europe Neuroscience Antibodies and Assays Market Size by Application (2022-2027)
7.3.3 Europe Neuroscience Antibodies and Assays Market Size by Application (2016-2027)
7.4 Europe Neuroscience Antibodies and Assays Market Size by Country
7.4.1 Europe Neuroscience Antibodies and Assays Market Size by Country (2016-2021)
7.4.2 Europe Neuroscience Antibodies and Assays Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Neuroscience Antibodies and Assays Market Size (2016-2027)
8.2 Asia-Pacific Neuroscience Antibodies and Assays Market Size by Type
8.2.1 Asia-Pacific Neuroscience Antibodies and Assays Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Neuroscience Antibodies and Assays Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Neuroscience Antibodies and Assays Market Size by Type (2016-2027)
8.3 Asia-Pacific Neuroscience Antibodies and Assays Market Size by Application
8.3.1 Asia-Pacific Neuroscience Antibodies and Assays Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Neuroscience Antibodies and Assays Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Neuroscience Antibodies and Assays Market Size by Application (2016-2027)
8.4 Asia-Pacific Neuroscience Antibodies and Assays Market Size by Region
8.4.1 Asia-Pacific Neuroscience Antibodies and Assays Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Neuroscience Antibodies and Assays Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Neuroscience Antibodies and Assays Market Size (2016-2027)
9.2 Latin America Neuroscience Antibodies and Assays Market Size by Type
9.2.1 Latin America Neuroscience Antibodies and Assays Market Size by Type (2016-2021)
9.2.2 Latin America Neuroscience Antibodies and Assays Market Size by Type (2022-2027)
9.2.3 Latin America Neuroscience Antibodies and Assays Market Size by Type (2016-2027)
9.3 Latin America Neuroscience Antibodies and Assays Market Size by Application
9.3.1 Latin America Neuroscience Antibodies and Assays Market Size by Application (2016-2021)
9.3.2 Latin America Neuroscience Antibodies and Assays Market Size by Application (2022-2027)
9.3.3 Latin America Neuroscience Antibodies and Assays Market Size by Application (2016-2027)
9.4 Latin America Neuroscience Antibodies and Assays Market Size by Country
9.4.1 Latin America Neuroscience Antibodies and Assays Market Size by Country (2016-2021)
9.4.2 Latin America Neuroscience Antibodies and Assays Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Neuroscience Antibodies and Assays Market Size (2016-2027)
10.2 Middle East & Africa Neuroscience Antibodies and Assays Market Size by Type
10.2.1 Middle East & Africa Neuroscience Antibodies and Assays Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Neuroscience Antibodies and Assays Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Neuroscience Antibodies and Assays Market Size by Type (2016-2027)
10.3 Middle East & Africa Neuroscience Antibodies and Assays Market Size by Application
10.3.1 Middle East & Africa Neuroscience Antibodies and Assays Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Neuroscience Antibodies and Assays Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Neuroscience Antibodies and Assays Market Size by Application (2016-2027)
10.4 Middle East & Africa Neuroscience Antibodies and Assays Market Size by Country
10.4.1 Middle East & Africa Neuroscience Antibodies and Assays Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Neuroscience Antibodies and Assays Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Thermo Fisher
11.1.1 Thermo Fisher Company Details
11.1.2 Thermo Fisher Business Overview
11.1.3 Thermo Fisher Neuroscience Antibodies and Assays Introduction
11.1.4 Thermo Fisher Revenue in Neuroscience Antibodies and Assays Business (2016-2021)
11.1.5 Thermo Fisher Recent Development
11.2 Abcam
11.2.1 Abcam Company Details
11.2.2 Abcam Business Overview
11.2.3 Abcam Neuroscience Antibodies and Assays Introduction
11.2.4 Abcam Revenue in Neuroscience Antibodies and Assays Business (2016-2021)
11.2.5 Abcam Recent Development
11.3 Bio-Rad
11.3.1 Bio-Rad Company Details
11.3.2 Bio-Rad Business Overview
11.3.3 Bio-Rad Neuroscience Antibodies and Assays Introduction
11.3.4 Bio-Rad Revenue in Neuroscience Antibodies and Assays Business (2016-2021)
11.3.5 Bio-Rad Recent Development
11.4 Merck
11.4.1 Merck Company Details
11.4.2 Merck Business Overview
11.4.3 Merck Neuroscience Antibodies and Assays Introduction
11.4.4 Merck Revenue in Neuroscience Antibodies and Assays Business (2016-2021)
11.4.5 Merck Recent Development
11.5 Cell Signaling Technology
11.5.1 Cell Signaling Technology Company Details
11.5.2 Cell Signaling Technology Business Overview
11.5.3 Cell Signaling Technology Neuroscience Antibodies and Assays Introduction
11.5.4 Cell Signaling Technology Revenue in Neuroscience Antibodies and Assays Business (2016-2021)
11.5.5 Cell Signaling Technology Recent Development
11.6 Genscript
11.6.1 Genscript Company Details
11.6.2 Genscript Business Overview
11.6.3 Genscript Neuroscience Antibodies and Assays Introduction
11.6.4 Genscript Revenue in Neuroscience Antibodies and Assays Business (2016-2021)
11.6.5 Genscript Recent Development
11.7 Rockland Immunochemicals
11.7.1 Rockland Immunochemicals Company Details
11.7.2 Rockland Immunochemicals Business Overview
11.7.3 Rockland Immunochemicals Neuroscience Antibodies and Assays Introduction
11.7.4 Rockland Immunochemicals Revenue in Neuroscience Antibodies and Assays Business (2016-2021)
11.7.5 Rockland Immunochemicals Recent Development
11.8 BioLegend
11.8.1 BioLegend Company Details
11.8.2 BioLegend Business Overview
11.8.3 BioLegend Neuroscience Antibodies and Assays Introduction
11.8.4 BioLegend Revenue in Neuroscience Antibodies and Assays Business (2016-2021)
11.8.5 BioLegend Recent Development
11.9 Santa Cruz Biotechnology
11.9.1 Santa Cruz Biotechnology Company Details
11.9.2 Santa Cruz Biotechnology Business Overview
11.9.3 Santa Cruz Biotechnology Neuroscience Antibodies and Assays Introduction
11.9.4 Santa Cruz Biotechnology Revenue in Neuroscience Antibodies and Assays Business (2016-2021)
11.9.5 Santa Cruz Biotechnology Recent Development
11.10 Roche
11.10.1 Roche Company Details
11.10.2 Roche Business Overview
11.10.3 Roche Neuroscience Antibodies and Assays Introduction
11.10.4 Roche Revenue in Neuroscience Antibodies and Assays Business (2016-2021)
11.10.5 Roche Recent Development
11.11 Siemens
11.11.1 Siemens Company Details
11.11.2 Siemens Business Overview
11.11.3 Siemens Neuroscience Antibodies and Assays Introduction
11.11.4 Siemens Revenue in Neuroscience Antibodies and Assays Business (2016-2021)
11.11.5 Siemens Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Neuroscience Antibodies and Assays Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Consumables
Table 3. Key Players of Instruments
Table 4. Global Neuroscience Antibodies and Assays Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Neuroscience Antibodies and Assays Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Neuroscience Antibodies and Assays Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Neuroscience Antibodies and Assays Market Share by Regions (2016-2021)
Table 8. Global Neuroscience Antibodies and Assays Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Neuroscience Antibodies and Assays Market Share by Regions (2022-2027)
Table 10. Neuroscience Antibodies and Assays Market Trends
Table 11. Neuroscience Antibodies and Assays Market Drivers
Table 12. Neuroscience Antibodies and Assays Market Challenges
Table 13. Neuroscience Antibodies and Assays Market Restraints
Table 14. Global Neuroscience Antibodies and Assays Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Neuroscience Antibodies and Assays Market Share by Players (2016-2021)
Table 16. Global Top Neuroscience Antibodies and Assays Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Neuroscience Antibodies and Assays as of 2020)
Table 17. Ranking of Global Top Neuroscience Antibodies and Assays Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Neuroscience Antibodies and Assays Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Neuroscience Antibodies and Assays Product Solution and Service
Table 21. Date of Enter into Neuroscience Antibodies and Assays Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Neuroscience Antibodies and Assays Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Neuroscience Antibodies and Assays Revenue Market Share by Type (2016-2021)
Table 25. Global Neuroscience Antibodies and Assays Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Neuroscience Antibodies and Assays Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Neuroscience Antibodies and Assays Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Neuroscience Antibodies and Assays Revenue Market Share by Application (2016-2021)
Table 29. Global Neuroscience Antibodies and Assays Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Neuroscience Antibodies and Assays Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Neuroscience Antibodies and Assays Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Neuroscience Antibodies and Assays Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Neuroscience Antibodies and Assays Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Neuroscience Antibodies and Assays Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Neuroscience Antibodies and Assays Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Neuroscience Antibodies and Assays Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Neuroscience Antibodies and Assays Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Neuroscience Antibodies and Assays Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Neuroscience Antibodies and Assays Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Neuroscience Antibodies and Assays Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Neuroscience Antibodies and Assays Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Neuroscience Antibodies and Assays Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Neuroscience Antibodies and Assays Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Neuroscience Antibodies and Assays Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Neuroscience Antibodies and Assays Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Neuroscience Antibodies and Assays Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Neuroscience Antibodies and Assays Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Neuroscience Antibodies and Assays Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Neuroscience Antibodies and Assays Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Neuroscience Antibodies and Assays Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Neuroscience Antibodies and Assays Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Neuroscience Antibodies and Assays Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Neuroscience Antibodies and Assays Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Neuroscience Antibodies and Assays Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Neuroscience Antibodies and Assays Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Neuroscience Antibodies and Assays Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Neuroscience Antibodies and Assays Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Neuroscience Antibodies and Assays Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Neuroscience Antibodies and Assays Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Neuroscience Antibodies and Assays Market Size by Country (2022-2027) & (US$ Million)
Table 61. Thermo Fisher Company Details
Table 62. Thermo Fisher Business Overview
Table 63. Thermo Fisher Neuroscience Antibodies and Assays Product
Table 64. Thermo Fisher Revenue in Neuroscience Antibodies and Assays Business (2016-2021) & (US$ Million)
Table 65. Thermo Fisher Recent Development
Table 66. Abcam Company Details
Table 67. Abcam Business Overview
Table 68. Abcam Neuroscience Antibodies and Assays Product
Table 69. Abcam Revenue in Neuroscience Antibodies and Assays Business (2016-2021) & (US$ Million)
Table 70. Abcam Recent Development
Table 71. Bio-Rad Company Details
Table 72. Bio-Rad Business Overview
Table 73. Bio-Rad Neuroscience Antibodies and Assays Product
Table 74. Bio-Rad Revenue in Neuroscience Antibodies and Assays Business (2016-2021) & (US$ Million)
Table 75. Bio-Rad Recent Development
Table 76. Merck Company Details
Table 77. Merck Business Overview
Table 78. Merck Neuroscience Antibodies and Assays Product
Table 79. Merck Revenue in Neuroscience Antibodies and Assays Business (2016-2021) & (US$ Million)
Table 80. Merck Recent Development
Table 81. Cell Signaling Technology Company Details
Table 82. Cell Signaling Technology Business Overview
Table 83. Cell Signaling Technology Neuroscience Antibodies and Assays Product
Table 84. Cell Signaling Technology Revenue in Neuroscience Antibodies and Assays Business (2016-2021) & (US$ Million)
Table 85. Cell Signaling Technology Recent Development
Table 86. Genscript Company Details
Table 87. Genscript Business Overview
Table 88. Genscript Neuroscience Antibodies and Assays Product
Table 89. Genscript Revenue in Neuroscience Antibodies and Assays Business (2016-2021) & (US$ Million)
Table 90. Genscript Recent Development
Table 91. Rockland Immunochemicals Company Details
Table 92. Rockland Immunochemicals Business Overview
Table 93. Rockland Immunochemicals Neuroscience Antibodies and Assays Product
Table 94. Rockland Immunochemicals Revenue in Neuroscience Antibodies and Assays Business (2016-2021) & (US$ Million)
Table 95. Rockland Immunochemicals Recent Development
Table 96. BioLegend Company Details
Table 97. BioLegend Business Overview
Table 98. BioLegend Revenue in Neuroscience Antibodies and Assays Business (2016-2021) & (US$ Million)
Table 99. BioLegend Recent Development
Table 100. Santa Cruz Biotechnology Company Details
Table 101. Santa Cruz Biotechnology Business Overview
Table 102. Santa Cruz Biotechnology Neuroscience Antibodies and Assays Product
Table 103. Santa Cruz Biotechnology Revenue in Neuroscience Antibodies and Assays Business (2016-2021) & (US$ Million)
Table 104. Santa Cruz Biotechnology Recent Development
Table 105. Roche Company Details
Table 106. Roche Business Overview
Table 107. Roche Neuroscience Antibodies and Assays Product
Table 108. Roche Revenue in Neuroscience Antibodies and Assays Business (2016-2021) & (US$ Million)
Table 109. Roche Recent Development
Table 110. Siemens Company Details
Table 111. Siemens Business Overview
Table 112. Siemens Neuroscience Antibodies and Assays Product
Table 113. Siemens Revenue in Neuroscience Antibodies and Assays Business (2016-2021) & (US$ Million)
Table 114. Siemens Recent Development
Table 115. Research Programs/Design for This Report
Table 116. Key Data Information from Secondary Sources
Table 117. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Neuroscience Antibodies and Assays Market Share by Type: 2020 VS 2027
Figure 2. Consumables Features
Figure 3. Instruments Features
Figure 4. Global Neuroscience Antibodies and Assays Market Share by Application: 2020 VS 2027
Figure 5. Pharmaceutical & Biotechnology Companies Case Studies
Figure 6. Academic & Research Institutes Case Studies
Figure 7. Hospitals & Diagnostic Centers Case Studies
Figure 8. Neuroscience Antibodies and Assays Report Years Considered
Figure 9. Global Neuroscience Antibodies and Assays Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Neuroscience Antibodies and Assays Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Neuroscience Antibodies and Assays Market Share by Regions: 2020 VS 2027
Figure 12. Global Neuroscience Antibodies and Assays Market Share by Regions (2022-2027)
Figure 13. Global Neuroscience Antibodies and Assays Market Share by Players in 2020
Figure 14. Global Top Neuroscience Antibodies and Assays Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Neuroscience Antibodies and Assays as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Neuroscience Antibodies and Assays Revenue in 2020
Figure 16. Global Neuroscience Antibodies and Assays Revenue Market Share by Type (2016-2021)
Figure 17. Global Neuroscience Antibodies and Assays Revenue Market Share by Type (2022-2027)
Figure 18. North America Neuroscience Antibodies and Assays Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Neuroscience Antibodies and Assays Market Share by Type (2016-2027)
Figure 20. North America Neuroscience Antibodies and Assays Market Share by Application (2016-2027)
Figure 21. North America Neuroscience Antibodies and Assays Market Share by Country (2016-2027)
Figure 22. United States Neuroscience Antibodies and Assays Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Neuroscience Antibodies and Assays Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Neuroscience Antibodies and Assays Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Neuroscience Antibodies and Assays Market Share by Type (2016-2027)
Figure 26. Europe Neuroscience Antibodies and Assays Market Share by Application (2016-2027)
Figure 27. Europe Neuroscience Antibodies and Assays Market Share by Country (2016-2027)
Figure 28. Germany Neuroscience Antibodies and Assays Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Neuroscience Antibodies and Assays Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Neuroscience Antibodies and Assays Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Neuroscience Antibodies and Assays Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Neuroscience Antibodies and Assays Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Neuroscience Antibodies and Assays Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Neuroscience Antibodies and Assays Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Neuroscience Antibodies and Assays Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Neuroscience Antibodies and Assays Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Neuroscience Antibodies and Assays Market Share by Region (2016-2027)
Figure 38. China Neuroscience Antibodies and Assays Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Neuroscience Antibodies and Assays Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Neuroscience Antibodies and Assays Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Neuroscience Antibodies and Assays Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Neuroscience Antibodies and Assays Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Neuroscience Antibodies and Assays Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Neuroscience Antibodies and Assays Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Neuroscience Antibodies and Assays Market Share by Type (2016-2027)
Figure 46. Latin America Neuroscience Antibodies and Assays Market Share by Application (2016-2027)
Figure 47. Latin America Neuroscience Antibodies and Assays Market Share by Country (2016-2027)
Figure 48. Mexico Neuroscience Antibodies and Assays Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Neuroscience Antibodies and Assays Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Neuroscience Antibodies and Assays Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Neuroscience Antibodies and Assays Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Neuroscience Antibodies and Assays Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Neuroscience Antibodies and Assays Market Share by Country (2016-2027)
Figure 54. Turkey Neuroscience Antibodies and Assays Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Neuroscience Antibodies and Assays Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Neuroscience Antibodies and Assays Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Thermo Fisher Revenue Growth Rate in Neuroscience Antibodies and Assays Business (2016-2021)
Figure 58. Abcam Revenue Growth Rate in Neuroscience Antibodies and Assays Business (2016-2021)
Figure 59. Bio-Rad Revenue Growth Rate in Neuroscience Antibodies and Assays Business (2016-2021)
Figure 60. Merck Revenue Growth Rate in Neuroscience Antibodies and Assays Business (2016-2021)
Figure 61. Cell Signaling Technology Revenue Growth Rate in Neuroscience Antibodies and Assays Business (2016-2021)
Figure 62. Genscript Revenue Growth Rate in Neuroscience Antibodies and Assays Business (2016-2021)
Figure 63. Rockland Immunochemicals Revenue Growth Rate in Neuroscience Antibodies and Assays Business (2016-2021)
Figure 64. BioLegend Revenue Growth Rate in Neuroscience Antibodies and Assays Business (2016-2021)
Figure 65. Santa Cruz Biotechnology Revenue Growth Rate in Neuroscience Antibodies and Assays Business (2016-2021)
Figure 66. Roche Revenue Growth Rate in Neuroscience Antibodies and Assays Business (2016-2021)
Figure 67. Siemens Revenue Growth Rate in Neuroscience Antibodies and Assays Business (2016-2021)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed

---